The Epilepsy-related gene testing of CapitalBio Technology is based on BES4000 semi-conductor sequencing platform, using target region capture and NGS technology together to detect the genes related epilepsy.
This panel covers 498 genetic diseases and 452 genes related to epilepsy.
Auxiliary diagnosis: looking for the pathogenicity reason of patients with suspected epilepsy, auxiliary clinical diagnosis.
Fertility guidance: provide fertility guidance for couples who have family history or have given birth to children.
Disease risk assessment: conduct risk assessment for high-risk groups with family history and provide early intervention programs to reduce the risk of disease.